Khanna Puneet, Sinha Chandni, Singh Akhil K, Kumar Ajeet, Sarkar Soumya
Department of Anaesthesia, Pain Medicine and Critical Care, AIIMS, New Delhi, India.
Department of Anesthesia, AIIMS, Patna, Bihar, India.
Saudi J Anaesth. 2023 Jan-Mar;17(1):23-32. doi: 10.4103/sja.sja_529_22. Epub 2023 Jan 2.
The utility of instantaneous evaluation of coagulation during primary postpartum haemorrhage (PPH) is paramount in the context of empirical blood product transfusion-related risk of dilutional and consumptive coagulopathy and circulatory overload.
A profound screening of electronic databases till August 15, 2022 was carried out after being enlisted in PROSPERO (CRD42021275514). Randomized control studies, comparative cohort studies, and cross-sectional studies comparing point-of-care viscoelastic test guided blood product transfusion with empirical transfusion in patients with PPH were included.
We retrieved five studies, with a total of 1914 parturient with PPH. Patients receiving transfusion based upon point of care viscoelastic tests had lesser risk of having emergency hysterectomy (Odds ratio (OR) = 0.55, 95% CI 0.32-0.95, I = 7%), transfusion-associated circulatory overload (TACO) (OR = 0.03, 95% CI 0.00-0.50), reduced transfusion of fresh frozen plasma (OR = 0.07, 95% CI 0.04-0.14, I = 89%), platelets (OR = 0.51, 95% CI 0.28-0.91, I = 89%), packed red blood cell transfusion (OR = 0.70, 95% CI 0.55-0.88, I = 89%), and had better cost-effective treatment [Mean difference (MD) = -357.5, 95% CI - 567.75 to -147.25, I = 93%] than patient received empirical transfusion. However, there was no significant difference in the requirement of ICU admissions (OR = 0.77, 95% CI = 0.46-1.29, I = 82%). No mortality was detected across the studies.
Point of care viscoelastic assessment guided transfusion in PPH confederates with reduced morbidity. Nevertheless, more studies on the triggering values for transfusion, long-term survival, and cost-benefit in patients with PPH are warranted to establish its utility.
在原发性产后出血(PPH)期间进行凝血功能的即时评估,对于因经验性输血导致稀释性和消耗性凝血病及循环超负荷相关风险而言至关重要。
在被纳入PROSPERO(CRD42021275514)后,对截至2022年8月15日的电子数据库进行了全面筛查。纳入了比较即时床旁粘弹性试验指导的输血与PPH患者经验性输血的随机对照研究、比较队列研究和横断面研究。
我们检索到五项研究,共有1914例PPH产妇。基于即时床旁粘弹性试验接受输血的患者进行急诊子宫切除术的风险较低(比值比(OR)=0.55,95%置信区间0.32 - 0.95,I² = 7%),输血相关循环超负荷(TACO)的风险较低(OR = 0.03,95%置信区间0.00 - 0.50),新鲜冰冻血浆输注量减少(OR = 0.07,95%置信区间0.04 - 0.14,I² = 89%),血小板输注量减少(OR = 0.51,95%置信区间0.28 - 0.91,I² = 89%),红细胞悬液输注量减少(OR = 0.70,95%置信区间0.55 - 0.88,I² = 89%),并且与接受经验性输血的患者相比具有更好的成本效益治疗[平均差(MD)=-357.5, 95%置信区间 -567.75至 -147.25,I² = 93%]。然而,入住重症监护病房的需求没有显著差异(OR = 0.77,95%置信区间 = 0.46 - 1.29,I² = 82%)。各项研究均未检测到死亡病例。
即时床旁粘弹性评估指导的PPH输血与发病率降低相关。然而,有必要对PPH患者输血的触发值、长期生存率和成本效益进行更多研究,以确定其效用。